(Q45366097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jerome de Seze

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Christine Lebrun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Marc Debouverie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Patrick Vermersch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lucien Rumbach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sandrine Wiertlevski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gilles Defer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Olivier Gout

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Frédéric Berthier

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Arlette Danzon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

399-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18420778%20AND%20SRC:MED&resulttype=core&format=json

Natural history of multiple sclerosis: a unifying concept

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Patterns of comorbidity in elderly patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Cancer incidence following hospitalization for multiple sclerosis in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Cancer risk among patients with multiple sclerosis: a population-based register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Malignant diseases among patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Multiple sclerosis and Hodgkin's disease in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Gliomatous transformation and demyelinating diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Establishment and use of multiple sclerosis registers--EDMUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

A stand-alone windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Multiple sclerosis associated with neurofibromatosis type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Concurrence of multiple sclerosis and brain tumor: clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Skin cancer in people with multiple sclerosis: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Overview of azathioprine treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Long-term safety of azathioprine therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Familial Clustering of Hodgkin Lymphoma and Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625

Lymphomas and Multiple Sclerosis in a Multicenter Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507083625